Let’s look at the key reasons that are pushing Evolent Health Inc (EVH) to new highs

Evolent Health Inc (NYSE: EVH) kicked off on Tuesday, down -5.01% from the previous trading day, before settling in for the closing price of $31.93. Over the past 52 weeks, EVH has traded in a range of $23.33-$36.70.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Healthcare Sector giant saw their annual sales surged by 27.32% over the last five years. While this was happening, its average annual earnings per share was recorded 23.81%. With a float of $109.55 million, this company’s outstanding shares have now reached $113.89 million.

The firm has a total of 4700 workers. Let’s measure their productivity.

Evolent Health Inc (EVH) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Evolent Health Inc is 5.09%, while institutional ownership is 110.28%. The most recent insider transaction that took place on Dec 05 ’23, was worth 3,741,475. In this transaction Chief Executive Officer of this company sold 141,000 shares at a rate of $26.54, taking the stock ownership to the 637,645 shares. Before that another transaction happened on Nov 15 ’23, when Company’s PRESIDENT sold 11,000 for $30.00, making the entire transaction worth $330,000. This insider now owns 198,333 shares in total.

Evolent Health Inc (EVH) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported $0.23 earnings per share (EPS), higher than consensus estimate (set at $0.15) by $0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 23.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to -13.43% drop over the previous five years of trading.

Evolent Health Inc (NYSE: EVH) Trading Performance Indicators

Take a look at Evolent Health Inc’s (EVH) current performance indicators. Last quarter, stock had a quick ratio of 1.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.78. Likewise, its price to free cash flow for the trailing twelve months is 30.75.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit 0.23 in the next quarter and is forecasted to reach 1.56 in one year’s time.

Technical Analysis of Evolent Health Inc (EVH)

Analysing the last 5-days average volume posted by the [Evolent Health Inc, EVH], we can find that recorded value of 0.89 million was lower than the volume posted last year of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 32.49%. Additionally, its Average True Range was 0.95.

During the past 100 days, Evolent Health Inc’s (EVH) raw stochastic average was set at 53.30%, which indicates a significant increase from 9.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.07% in the past 14 days, which was lower than the 40.83% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $31.90, while its 200-day Moving Average is $29.32. Now, the first resistance to watch is $31.40. This is followed by the second major resistance level at $32.48. The third major resistance level sits at $33.21. If the price goes on to break the first support level at $29.60, it is likely to go to the next support level at $28.87. Now, if the price goes above the second support level, the third support stands at $27.79.

Evolent Health Inc (NYSE: EVH) Key Stats

The company with the Market Capitalisation of 3.50 billion has total of 115,430K Shares Outstanding. Its annual sales at the moment are 1,964 M in contrast with the sum of -113,040 K annual income. Company’s last quarter sales were recorded 556,060 K and last quarter income was -33,410 K.